NFLX is at support, which has held a few times already.
Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot.
I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot.
I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.